Literature DB >> 2570631

Cardioprotective effect of metipranolol on ischemic heart muscle.

J Gvozdják1, A Gvozdjáková, J Kucharská, V Bada.   

Abstract

The effect of the beta-adrenoceptor antagonist metipranolol given twice daily in a dose of 0.5 mg/kg body weight for 3 days on respiration, respiratory control index of mitochondria and oxidative phosphorylation was measured in the heart muscle of anesthetized dogs after 60 min of induced ischemia. In control animals pretreated with saline, all measured variables with the exception of the coefficient of oxidative phosphorylation were significantly decreased. In contrast, pretreatment with metipranolol significantly improved all measured myocardial metabolic variables. The effect of metipranolol on the oxidative phosphorylating processes was more pronounced when the metabolic substrate was glutamate than when it was pyruvate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570631     DOI: 10.1159/000174492

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  1 in total

1.  Metipranolol attenuates lipid peroxidation in rat brain: a comparative study with other antiglaucoma drugs.

Authors:  José Melena; Neville N Osborne
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-07-29       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.